Degenerative Disc Disease Treatment Market
Degenerative Disc Disease Treatment Market Forecasts to 2030 - Global Analysis By Type (Conventional Drugs, Novel Therapies and Other Types), Treatment Type, Route of Administration, End User and by Geography
|
Years Covered |
2022-2030 |
|
Estimated Year Value (2024) |
US $32.36 BN |
|
Projected Year Value (2030) |
US $49.94 BN |
|
CAGR (2024 - 2030) |
7.5% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Degenerative Disc Disease Treatment Market is accounted for $32.36 billion in 2024 and is expected to reach $49.94 billion by 2030 growing at a CAGR of 7.5% during the forecast period. Degenerative Disc Disease (DDD) treatment focuses on alleviating pain, improving mobility, and slowing the progression of spinal degeneration. Treatment options can vary from conservative measures to surgical interventions, depending on how severe the condition is. Physical therapy is one form of conservative treatment that improves support and lessens strain on the damaged discs by strengthening the muscles surrounding the spine. Injections of corticosteroids, muscle relaxants, and nonsteroidal anti-inflammatory drugs (NSAIDs) are examples of pain management techniques that help lessen discomfort and inflammation.
According to the National Institutes of Health (NIH), nearly 80% of people experience low back pain at some point in their lives, and degenerative disc disease is a common cause of this pain.
Market Dynamics:
Driver:
Increased frequency of immune conditions
Degenerative disc diseases are known to be influenced by the rising incidence of autoimmune disorders. DDD symptoms may worsen as a result of inflammation and degeneration of the spinal structures caused by diseases like rheumatoid arthritis. Patients in need of specialized treatment for DDD are increasing in number as autoimmune diseases become more prevalent worldwide, partly as a result of environmental factors and changes in lifestyle. Additionally, this pattern highlights the requirement for integrated care strategies that deal with degenerative disc problems and autoimmune diseases concurrently.
Restraint:
Exorbitant surgical intervention costs
The high expense of surgical procedures for degenerative disc disease, such as discectomy, spinal fusion, and artificial disc replacement, can prevent patients from receiving these treatments. Due to insufficient insurance coverage or high out-of-pocket costs for these procedures, many people encounter financial difficulties. Potential market growth may be limited if patients are discouraged from seeking necessary surgical interventions due to financial burdens. Furthermore, patients may be deterred from pursuing surgical solutions by post-surgical complications like bleeding, nerve damage, and inflammation because they are afraid of the unfavorable results.
Opportunity:
Raising patient involvement and awareness
Due to the efforts and educational campaigns of healthcare providers, there is a growing public awareness of degenerative disc disease and spine health. People are encouraged to seek medical attention for DDD symptoms early in the disease's progression as a result of this increased awareness. The demand for different treatment modalities rises in tandem with patients increased proactivity in maintaining their spinal health. Moreover, through community outreach initiatives, support groups, and educational materials, this trend gives healthcare organizations and providers a chance to interact with patients and ultimately improve patient outcomes and satisfaction.
Threat:
Market saturation and intense competition
There is fierce competition in the DDD treatment market from many players providing a variety of treatment options, ranging from cutting-edge surgical interventions to conservative therapies. Price wars resulting from this saturation may lower manufacturer’s profit margins and deter investment in R&D. Furthermore, differentiation gets harder as more businesses enter the market with comparable products, which could cause market fragmentation. To stay competitive, businesses must constantly innovate, which can be risky and resource-intensive.
Covid-19 Impact:
The market for treatments for Degenerative Disc Disease (DDD) has been severely impacted by the COVID-19 pandemic, mainly as a result of the reallocation of medical resources and the disruption of healthcare services. Many elective surgeries, including those for degenerative disc disease, were cancelled or postponed as hospitals and clinics concentrated on managing COVID-19 cases. Patients requiring surgical care for spinal conditions experienced severe delays as a result. Additionally, reducing demand for DDD treatments was a shift in patient behaviour brought about by the pandemic. Many people were reluctant to seek in-person medical care because they were afraid of spreading the virus.
The Occupational Therapy segment is expected to be the largest during the forecast period
The segment with the largest share is occupational therapy. This strategy aims to enhance people's quality of life and assist them in managing their everyday activities in spite of the limitations imposed by degenerative disc disease. Personalized treatment plans, including functional training, adaptive strategies, and ergonomic evaluations to lessen spinal strain, are commonly used in occupational therapy for DDD patients. Moreover, therapists collaborate with patients to create pain management plans, improve mobility, and improve day-to-day functioning. Occupational therapy has become more popular as a result of the growing understanding of the value of comprehensive and patient-centered care in the management of chronic conditions.
The Hospitals segment is expected to have the highest CAGR during the forecast period
Over the course of the forecast period, the hospital segment is anticipated to show the highest CAGR. This growth is explained by the growing number of hospitals with specialized departments that are outfitted with cutting-edge diagnostic equipment and treatment plans designed specifically to manage degenerative disc diseases. In order to treat DDD effectively, hospitals offer a wide range of services, such as physical therapy, pain management, and surgical interventions. Furthermore, the incorporation of state-of-the-art technologies, like minimally invasive surgical methods and improved imaging capacities, adds to hospitals attractiveness as the principal treatment destinations for individuals with spinal disorders.
Region with largest share:
The market for treatments for degenerative disc disease (DDD) is dominated by the North American region. The primary reasons for this dominance are the high prevalence of degenerative disc disease and chronic back pain in the population, as well as a robust healthcare system that makes access to state-of-the-art treatment options possible. The region's healthcare system is distinguished by large expenditures on R&D, which result in the acceptance of cutting-edge treatments and tools for DDD management. Additionally, there is a growing trend of major market players merging and acquiring one another, which increases the availability of innovative treatment options.
Region with highest CAGR:
Over the course of the forecast period, the Degenerative Disc Disease (DDD) Treatment Market is expected to grow at the highest CAGR in the Asia-Pacific region. The population's increased occurrence of degenerative diseases and chronic low back pain, along with rising healthcare expenditures targeted at enhancing treatment accessibility, are some of the factors contributing to this growth. Effective DDD treatments are in greater demand as nations in this region improve their diagnostic and therapeutic capacities as well as their healthcare infrastructure. Moreover, driving market growth is anticipated to come from market participants' attempts to obtain regulatory approvals for novel therapies and clinical trials in countries such as South Korea and Japan.
Key players in the market
Some of the key players in Degenerative Disc Disease Treatment market include Novartis AG, Eli Lilly and Company, AstraZeneca Plc, Spine BioPharma Inc., Medtronic plc, DiscGenics, Inc., Johnson & Johnson Services, Inc., Abbott Laboratories, Stryker, Ferring B.V., Pfizer Inc., Globus Medical, Inc., B. Braun Melsungen AG, Ensol Biosciences Inc. and Zimmer Biomet Holdings, Inc.
Key Developments:
In July 2024, Spine BioPharma, Inc., a company committed to developing non-opiate, non-surgical therapies for the treatment of pain related disabilities, announced that it has signed an agreement with Korean Company Ensol BioSciences, Inc. to expand the indications of its therapeutic drug treatment candidate, SB-01 For Injection.
In June 2024, Novartis has entered an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a Germany-based, global biopharmaceutical company developing oncology medicines, for €2.7 billion. The acquisition, subject to customary closing conditions, further expands Novartis’ oncology pipeline as well as its global footprint in hematology.
In May 2024, AstraZeneca has entered a worldwide licence and option agreement with Nona Biosciences for a preclinical monoclonal antibody. The deal focuses on the development of the antibody to develop targeted tumour therapies. Nona is eligible to receive $19m from AstraZeneca upon completion of the deal.
Types Covered:
• Conventional Drugs
• Novel Therapies
• Other Types
Treatment Types Covered:
• Occupational Therapy
• Physical Therapy
• Special Exercises
• Medications
• Weight Loss Surgery
• Other Treatment Types
Route of Administrations Covered:
• Oral
• Injectable
End Users Covered:
• Hospitals
• Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Degenerative Disc Disease Treatment Market, By Type
5.1 Introduction
5.2 Conventional Drugs
5.2.1 Acetaminophen
5.2.2 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
5.2.3 Corticosteroids
5.2.4 Muscle Relaxants
5.2.5 Opioids
5.3 Novel Therapies
5.3.1 Cell Therapy
5.3.2 Platelet Rich Plasma (PRP)
5.4 Other Types
6 Global Degenerative Disc Disease Treatment Market, By Treatment Type
6.1 Introduction
6.2 Occupational Therapy
6.3 Physical Therapy
6.4 Special Exercises
6.5 Medications
6.6 Weight Loss Surgery
6.7 Other Treatment Types
7 Global Degenerative Disc Disease Treatment Market, By Route of Administration
7.1 Introduction
7.2 Oral
7.3 Injectable
8 Global Degenerative Disc Disease Treatment Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Clinics
8.4 Other End Users
9 Global Degenerative Disc Disease Treatment Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Novartis AG
11.2 Eli Lilly and Company
11.3 AstraZeneca Plc
11.4 Spine BioPharma Inc.
11.5 Medtronic plc
11.6 DiscGenics, Inc.
11.7 Johnson & Johnson Services, Inc.
11.8 Abbott Laboratories
11.9 Stryker
11.10 Ferring B.V.
11.11 Pfizer Inc.
11.12 Globus Medical, Inc.
11.13 B. Braun Melsungen AG
11.14 Ensol Biosciences Inc.
11.15 Zimmer Biomet Holdings, Inc.
List of Tables
1 Global Degenerative Disc Disease Treatment Market Outlook, By Region (2022-2030) ($MN)
2 Global Degenerative Disc Disease Treatment Market Outlook, By Type (2022-2030) ($MN)
3 Global Degenerative Disc Disease Treatment Market Outlook, By Conventional Drugs (2022-2030) ($MN)
4 Global Degenerative Disc Disease Treatment Market Outlook, By Acetaminophen (2022-2030) ($MN)
5 Global Degenerative Disc Disease Treatment Market Outlook, By Non-steroidal Anti-inflammatory Drugs (NSAIDs) (2022-2030) ($MN)
6 Global Degenerative Disc Disease Treatment Market Outlook, By Corticosteroids (2022-2030) ($MN)
7 Global Degenerative Disc Disease Treatment Market Outlook, By Muscle Relaxants (2022-2030) ($MN)
8 Global Degenerative Disc Disease Treatment Market Outlook, By Opioids (2022-2030) ($MN)
9 Global Degenerative Disc Disease Treatment Market Outlook, By Novel Therapies (2022-2030) ($MN)
10 Global Degenerative Disc Disease Treatment Market Outlook, By Cell Therapy (2022-2030) ($MN)
11 Global Degenerative Disc Disease Treatment Market Outlook, By Platelet Rich Plasma (PRP) (2022-2030) ($MN)
12 Global Degenerative Disc Disease Treatment Market Outlook, By Other Types (2022-2030) ($MN)
13 Global Degenerative Disc Disease Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
14 Global Degenerative Disc Disease Treatment Market Outlook, By Occupational Therapy (2022-2030) ($MN)
15 Global Degenerative Disc Disease Treatment Market Outlook, By Physical Therapy (2022-2030) ($MN)
16 Global Degenerative Disc Disease Treatment Market Outlook, By Special Exercises (2022-2030) ($MN)
17 Global Degenerative Disc Disease Treatment Market Outlook, By Medications (2022-2030) ($MN)
18 Global Degenerative Disc Disease Treatment Market Outlook, By Weight Loss Surgery (2022-2030) ($MN)
19 Global Degenerative Disc Disease Treatment Market Outlook, By Other Treatment Types (2022-2030) ($MN)
20 Global Degenerative Disc Disease Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
21 Global Degenerative Disc Disease Treatment Market Outlook, By Oral (2022-2030) ($MN)
22 Global Degenerative Disc Disease Treatment Market Outlook, By Injectable (2022-2030) ($MN)
23 Global Degenerative Disc Disease Treatment Market Outlook, By End User (2022-2030) ($MN)
24 Global Degenerative Disc Disease Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
25 Global Degenerative Disc Disease Treatment Market Outlook, By Clinics (2022-2030) ($MN)
26 Global Degenerative Disc Disease Treatment Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
